Aprogen Healthcare & Games Inc (109960) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Aprogen Healthcare & Games Inc (109960) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩699.57 Million ≈ $474.09K USD) by net assets (₩309.52 Billion ≈ $209.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Aprogen Healthcare & Games Inc fund operations to measure how many days the company can operate on defensive assets alone.

Aprogen Healthcare & Games Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Aprogen Healthcare & Games Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aprogen Healthcare & Games Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aprogen Healthcare & Games Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GE Power India Limited NSE:GEPIL	1.009x
Deo Ca Traffic Infrastructure Investment JSC VN:HHV	0.009x
Motorcar Parts of America Inc NASDAQ:MPAA	-0.032x
Electromed Inc NYSE MKT:ELMD	0.067x
TCI Express Limited NSE:TCIEXP	0.026x
Supermax Corporation Bhd KLSE:7106	0.001x
CS Disco LLC NYSE:LAW	-0.094x
Roda Vivatex Tbk JK:RDTX	0.003x

Annual Cash Flow Conversion Efficiency for Aprogen Healthcare & Games Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Aprogen Healthcare & Games Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Aprogen Healthcare & Games Inc (109960) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩301.81 Billion ≈ $204.53 Million	₩4.71 Billion ≈ $3.19 Million	0.016x	+169.57%
2023-12-31	₩287.26 Billion ≈ $194.68 Million	₩1.66 Billion ≈ $1.13 Million	0.006x	-93.34%
2022-12-31	₩198.89 Billion ≈ $134.78 Million	₩17.28 Billion ≈ $11.71 Million	0.087x	+245.56%
2021-12-31	₩222.62 Billion ≈ $150.86 Million	₩-13.29 Billion ≈ $-9.01 Million	-0.060x	-508.77%
2020-12-31	₩231.83 Billion ≈ $157.11 Million	₩3.39 Billion ≈ $2.29 Million	0.015x	+211.79%
2019-12-31	₩210.50 Billion ≈ $142.65 Million	₩986.07 Million ≈ $668.25K	0.005x	-76.65%
2018-12-31	₩217.46 Billion ≈ $147.37 Million	₩4.36 Billion ≈ $2.96 Million	0.020x	+213.50%
2017-12-31	₩114.81 Billion ≈ $77.80 Million	₩734.70 Million ≈ $497.89K	0.006x	+100.57%
2016-12-31	₩8.64 Billion ≈ $5.86 Million	₩-9.71 Billion ≈ $-6.58 Million	-1.124x	-759.29%
2015-12-31	₩15.08 Billion ≈ $10.22 Million	₩-1.97 Billion ≈ $-1.34 Million	-0.131x	-147.38%
2013-12-31	₩4.40 Billion ≈ $2.98 Million	₩1.22 Billion ≈ $823.57K	0.276x	--

About Aprogen Healthcare & Games Inc

KQ:109960 Korea Pharmaceuticals

Market Cap

$222.70 Million

₩328.62 Billion KRW

Market Cap Rank

#16219 Global

#584 in Korea

Share Price

₩1839.00

Change (1 day)

+0.05%

52-Week Range

₩150.00 - ₩2300.00

All Time High

₩20250.00